High Risk Gross Tumor Volume Boost HR GTV Boost Contour Delineation Agreement among RTOG Sarcoma Radiation and Surgical Oncologists Elizabeth H Baldini MD MPH DanaFarber Cancer InstituteBrigham and Womens Hospital ID: 775716
Download Presentation The PPT/PDF document " Retroperitoneal Sarcoma (RPS) " is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Retroperitoneal Sarcoma (RPS) High Risk Gross Tumor Volume Boost (HR GTV Boost) Contour Delineation Agreement among RTOG Sarcoma Radiation and Surgical Oncologists Elizabeth H Baldini MD, MPHDana-Farber Cancer Institute/Brigham and Women’s Hospital
CTOS
October 16, 2014
Slide2Contributing Authors
E Baldini, C RautD Wang, R Abrams, K MillikanK Salerno, J KaneC Deville, G KarakousisI Petersen, M KendrickT DeLaney, Y Chen, J MullenW Bosch
Dana-Farber/Brigham & Women’sRush University Medical CenterRoswell Park Cancer InstituteUniversity of PennsylvaniaMayo ClinicMassachusetts General HospitalWashington University
Supported by grants U10CA21661, U10CA180868, U10CA180822
,
U10CA37422
, U24CA180803 from the National Cancer Institute
Slide3Background
Only proven curative intent treatment modality for RPS is surgeryRole of pre-op RT has not been proven and is the subject of a randomized trial: EORTC STRASS 62092In the meantime, many multi-disciplinary teams employ pre-op RT for RPS and consensus guidelines have been developed for delineation of RT target volumes*
*CTOS, New York, 2013
Slide4Background
Further, there is interest in delivering a “boost” dose of RT to high risk areas of the tumor volume judged to be at risk for positive margins following resectionThis is being tested in a multi-center Phase I/II trial among several US NRG institutions (PI: DeLaney)
Gross Tumor
Volume(GTV)
High Risk Boost Volume
Slide5Radiation Target Volume Definitions
GTV: Gross Tumor VolumeCTV: Clinical Target Volume- GTV plus adjacent areas of potential microscopic diseaseHigh Risk GTV (HR GTV): Area of GTV judged to be at high risk of positive margins after resection
GTV: red
CTV: yellow
GTV: red
HR GTV: pink
Slide6Background
Target VolumeKappa AgreementRPS1RPS2Gross Tumor Volume(GTV)0.84 Almost Perfect0.92 Almost PerfectClinical Target Volume(CTV)0.79 Substantial0.86 Almost PerfectHR Boost Volume0.50 Moderate0.57 Moderate
HR Boost Volume contour agreement was suboptimal More clarification of this boost target volume is needed Basis of the current project
Variability of RPS target volume contour delineation among Sarcoma Radiation Oncologists has recently been assessed**
**ASTRO, San Francisco, 2014
Slide7Purpose
To evaluate the variability in HR GTV Boost target volume delineation among sarcoma radiation and surgical oncology teams
Slide8Methods
Radiation planning CT scans for 3 cases of RPS were distributed to 7 radiation and surgical oncology teams
GTV (gross tumor volume) and organ contours were provided
Teams were asked to contour HR GTV Boost volumes for each case
Slide9HR GTV Boost Contour Instructions
Area considered to be at high risk for positive margins following resectionGenerally areas of tumor located along posterior RP musculature, ipsilateral pre-vertebral space, major vessels, or organs the surgeon would leave in situContour 1.5 cm thick
High Risk Boost Volume
GTV
Slide10Methods: Analysis of Contour Agreement
Simultaneous truth and performance level estimation (STAPLE) algorithm* Kappa statistics (yield values from -1 to +1)Kappa = -1 : complete disagreementKappa = +1 : complete agreementDescriptive categories for interpretation of strength** Kappa < 0 is poor 0.00 - 0.20 is slight 0.21 - 0.40 is fair 0.41 - 0.60 is moderate 0.61 - 0.80 is substantial 0.81 - 1.00 is almost perfect agreement
*Warfield, IEEE Transactions on Medical Imaging 2004;23:903
** Landis, Biometrics 1977;33:159
Slide11Results
Each case was contoured by 7 radiation and surgical oncology teams
First case: RPS 1
De-differentiated (DD) liposarcoma (LPS) of right upper quadrant
Second case: RPS 2
Leiomyosarcoma (LMS) of left upper quadrant
Third case: RPS 3
DD LPS of left lower quadrant with extension through inguinal canal into upper scrotum
Slide12Results HR GTV Boost Volume Contour Agreement
Kappa AgreementRPS 1: DD LPS right upper quadrant0.66 ModerateRPS 2: LMS left upper quadrant0.61 ModerateRPS 3: DD LPS left lower quadrant0.52 Moderate
Slightly better agreement than prior consensus project (0.50, 0.57)
Contour agreement for all cases was only moderate
Slide13HR GTV: Very Good Agreement
RPS 2: LUQ LMS
Very good contour agreement laterally along chest wall and medially along ipsilat para-vertebral space and aorta
Red: GTV
Other colors: HR GTV volumes
Slide14HR GTV: Marginal Agreement
Red: GTV
Other colors: HR GTV volumes
RPS 3: LLQ DD LPS
Marginal
contour agreement medially along bladder and
anteriorly
along anterior abdominal wall
Slide15HR GTV: Marginal Agreement
Red: GTVOther colors: HR GTV volumes
RPS 1:RUQ DD LPSMarginal agreement along liver 4 contours include entire liver surface in contact with tumor, 3 contours exclude liver
Slide16Conclusion
Overall agreement for HR GTV boost volumes was moderate
Contour agreement was best:
Postero
-laterally, abutting chest wall
Medially, abutting RP musculature, ipsilateral para-vertebral space, great vessels
Contour agreement most variable:
Abutting organs such as liver and bladder
Discrepancies are explained by differing surgical opinions regarding partial organ resections for these cases
Highlights extreme importance of collaboration between radiation and surgical oncologist for each patient
Slide17Future Directions
Further discussion among sarcoma radiation and surgical oncologists is needed to reach improved consensus
An atlas with detailed examples of HR GTV volumes may be an effective educational tool